Search

everythinglearnresearchcommunity

for

Search:↓

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Male hormones can decrease the ability of immune cells to fight bacteria.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

Muscles can make their own androgens, which may help muscle growth.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

An ovarian tumor can cause high male hormones in postmenopausal women.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

PCOS may increase eye pressure and corneal thickness, affecting eye health.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.